Stephens Consulting, LLC Neogenomics Inc Transaction History

Stephens Consulting, LLC

$399 Billion
Q1 2025

A detailed history of Stephens Consulting, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Stephens Consulting, LLC holds 40 shares of NEO stock, worth $382. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$382

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 Apr 17, 2025	BUY	$9.09 - $18.61 $363 - $744	40 New	40 $380,000
Q2 2024 Jul 29, 2024	BUY	$13.01 - $15.77 $1,131 - $1,371	87 New	87 $1.21 Million

Others Institutions Holding NEO

# of Institutions

279

Shares Held

124M

Call Options Held

751K

Put Options Held

107K

Black Rock Inc. New York, NY

19.7M
Shares

$188 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14.2M
Shares

$136 Million
0.0% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.53M
Shares

$62.3 Million
0.07% of portfolio
Janus Henderson Group PLC London, X0

6.17M
Shares

$58.9 Million
0.05% of portfolio
Brown Advisory Inc

6.16M
Shares

$58.8 Million
0.13% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.2B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stephens Consulting, LLC with notifications on news.

Account